Key facts
- This page summarizes Stein Robert Benjamin's Form 4 filing for MIMEDX GROUP, INC. (MDXG).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 08 Aug 2022, 17:43.
Stein Robert Benjamin - 04 Aug 2022 Form 4 Insider Report for MIMEDX GROUP, INC. (MDXG)
- Reporting relationship
- President, Regenerative Med.
- Issuer ticker
- MDXG
- Reported as of
- 04 Aug 2022
- Net transaction value
- -$70,590
- SEC form
- 4
- Accepted by SEC
- 08 Aug 2022, 17:43:17 UTC
- Prior SEC filing
- 30 Jun 2022
- Next SEC filing
- 16 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ William F. Hulse as attorney in fact for Robert Benjamin Stein
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stein Robert Benjamin filed Form 4 for MIMEDX GROUP, INC. (MDXG) on 08 Aug 2022.
Change
- Previous filing in this sequence was filed on 30 Jun 2022.
- Current net transaction value: -$70,590.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MDXG
transaction
Common Stock
Sale
- Transaction value
- $70,590
- Shares
- -19,500
- Change %
- -5.8%
- Price
- $3.62
- Shares after
- 314,505
- Date
- 04 Aug 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.